reduced l glutathione vs s acetyl S-Acetyl L-Glutathione Supplement S-Acetyl Glutathione Synergy | Superior
Description
In September 2023, the FDA moved BPC-157 into Category 2 of its 503A bulk substances list, restricting its use in compounding pharmacies pending further review

Although BPC-157 has been proven safe and well-tolerated in clinical trials, there are potential risks such as allergic reactions, interactions with other medications, and unknown long-term effects

Each ml contains: Cyanocobalamin (Vitamin B12) 1000 mcg

The cardiac progenitor activation data from Smart et al

BPC-157 is currently an investigational compound and is not FDA-approved to treat, cure, or prevent any specific disease
